CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teijin Limited v. Roxane Laboratories Inc.

1:14-cv-00189

Overview

Case Number 1:14-cv-00189
Filing Date 2014-02-12
Status Terminated
Termination Date 2016-05-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Roxane Laboratories Inc. Operating Company

Represented By

4 Attorneys Listed

Myoka Kim Goodin

Email: mkgoodin@lockelord.com

James T. Peterka

Email: jpeterka@lockelord.com

Alan B. Clement

Email: aclement@lockelord.com

Francis J. Murphy , Jr.

Murphy, Spadaro & Landon

Tel: +1 (302) 472-8100

Murphy, Spadaro & Landon, 1011 Centre Road

Plaintiff

Takeda Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

Zhiqiang Liu

Email: zliu@pbwt.com

Willam F Cavanaugh , Jr.

Email: wfcavanaugh@pbwt.com

Scott B. Howard

Email: sbhoward@pbwt.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Pharma Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Teijin Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Melanie R. Rupert

Email: melanierupert@paulhastings.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jason T. Christiansen

Email: jasonchristiansen@paulhastings.com

James T. Evans

Email: jamesevans@paulhastings.com

David M. Conca

Email: davidconca@paulhastings.com

Bruce M. Wexler

Email: brucewexler@paulhastings.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 8 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇯🇵 Japan 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (8 found):
U.S. Courts: 8
U.S. District Court 2015-06-04
1:15-cv-00454

Teijin Limited v. Macleods Pharmaceuticals Ltd.

U.S. Family Sibling (["US7361676"])
Status: DED
U.S. District Court 2014-11-04
1:14-cv-01370

Teijin Limited v. Unimark Remedies Ltd.

U.S. Family Sibling (["US7361676", "US8372872"])
Status: DED
U.S. District Court 2014-07-01
1:14-cv-00854

Teijin Limited v. Prinston Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-07
1:14-cv-00166

Teijin Limited v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-12-23
1:13-cv-02086

Teijin Limited v. Zydus Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-11-19
1:13-cv-01939

Teijin Limited v. Alembic Pharmaceuticals Limited

Asserted Patent
Status: DED
U.S. District Court 2013-11-06
1:13-cv-01851

Teijin Limited v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-10-30
1:13-cv-01780

Teijin Limited v. Dr. Reddy's Laboratories Ltd.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6225474
Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
Filed: 1999-06-18
Issued: 2001-05-01
Expired (Term Ended)
Expires: 2019-06-18
US7361676
Solid preparation containing single crystal form
Filed: 2003-03-28
Issued: 2008-04-22
Expired (Term Ended) +346d PTA
Expires: 2024-03-08
US8372872
Methods for concomitant treatment of theophylline and febuxostat
Filed: 2011-11-14
Issued: 2013-02-12
Active (5.0 yrs remaining)
Expires: 2031-11-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

2

Denied

0

Pending / Review

5

Motions by Category

Claim Construction / Markman Filing 1 Procedural / Extension Motion 9

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION and Proposed Order to Extend Time to Answer 1st Amended Complaint re 68 Amended Complaint by Roxane Laboratories Inc.. (Murphy, Francis) (Entered: 0...
Entry #77 • 2016-01-28 Document →
Procedural / Extension Motion Granted
MEMORANDUM ORDER granting 38 MOTION for Leave to File First Amended Complaint filed by Takeda Pharmaceuticals USA Inc., Teijin Pharma Limited, Teiji...
Entry #67 • 2016-01-14 Document →
Procedural / Extension Motion Pending / Under Review
REPLY BRIEF re 38 MOTION for Leave to File First Amended Complaint filed by Takeda Pharmaceuticals USA Inc., Teijin Limited, Teijin Pharma Limited. (Noreika, Ma...
Entry #48 • 2015-11-17 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file their reply brief in support of their Motion for Leave to File First Amended Complaint to November 17, 2015 - ...
Entry #46 • 2015-11-13 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 46 STIPULATION TO EXTEND TIME for Plaintiffs to file their reply brief in support of their Motion for Leave to File First Amended Complaint to No...
Entry #— • 2015-11-13
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to file their reply brief in support of their Motion for Leave to File First Amended Complaint to November 12, 2015 - ...
Entry #44 • 2015-11-04 Document →

Docket Entries

(164 total)
Pleading / Complaint

COMPLAINT - filed against Roxane Laboratories Inc.. Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1461022.) - filed by Teijin Pharma Limited, Teijin Limited, Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mdb) (Entered: 02/14/2014)

Entry #1 • 2014-02-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mdb) (Entered: 02/14/2014)

Entry #2 • 2014-02-12
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/4/14. Date of Expiration of Patent: 6/18/19.Thirty Month Stay Deadline: 8/13/2016. (mdb) (Entered: 02/14/2014)

Entry #3 • 2014-02-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,225,474 B1;. (mdb) (Entered: 02/14/2014)

Entry #4 • 2014-02-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda American Holdings Inc., Other Affiliate Takeda Pharmaceutical Company Limited for Takeda Pharmaceuticals USA Inc. filed by Takeda Pharmaceuticals USA Inc.. (mdb) (Entered: 02/14/2014)

Entry #5 • 2014-02-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc